Background Obesity and lack of physical activity are frequently reported in persons with intellectual disability (ID) or autism spectrum disorder (ASD). We hypothesised a higher prevalence of diabetes and hypertension in this population. Method We used administrative data for all primary and specialist outpatient and inpatient healthcare consultations for people with at least one recorded diagnosis of diabetes mellitus, hypertension or obesity from 1998 to 2015. Data were drawn from the central administrative database for Stockholm County, Sweden. It was not possible to separate data for type 1 and type 2 diabetes. We stratified 26 988 individuals with IDs or ASD into three groups, with Down syndrome treated separately, and compared these groups with 1 996 140 people from the general population.
Background
From a young age, overweight and obesity are reported to be more prevalent in persons with intellectual disabilities (IDs) than in the general population (GP) (Hove 2004; Melville et al. 2007; Emerson 2009; Lloyd et al. 2012) . This may be partly attributed to specific syndromes and elevated prescriptions of psychotropic medication known to contribute to obesity (Melville et al. 2007) . However, the nature and extent of health inequalities experienced by individuals with IDs are well known (Emerson et al. 2016b) . Type 2 diabetes and hypertension are common in overweight and obese individuals (Haslam & James 2005) . Type 2 diabetes is also more common among people with a previous diagnosis of hypertension (Lastra et al. 2014) . Both type 2 diabetes and hypertension are preventable with healthier lifestyle choices, including less sedentary time, increased physical activity and healthier food (Wilmot et al. 2012) . Evidence-based preventive strategies targeting individuals with IDs have been developed (Taggart & Cousins 2014) . Type 2 diabetes develops when the body can no longer produce enough insulin or is unable to effectively use produced insulin to keep blood sugar levels normal, whereas type 1 diabetes is caused by an autoimmune disorder in which the body is unable to use blood glucose (Fox et al. 2015) . For people with type 2 diabetes and hypertension, treatment and support to change unhealthy lifestyle factors are as important as basic treatment. Although type 1 diabetes is not preventable by health promotion, a healthy lifestyle is essential for those who have developed the condition.
Around 1-2% of the population has an ID, with most being mild IDs (Gillberg & Soderstrom 2003; Maulik et al. 2011) . Some ID diagnoses are associated with an increased prevalence of diabetes mellitus and hypertension. Diabetes is reported to be more prevalent in individuals with diagnoses such as Prader-Willi syndrome, possibly explained by obesity (Brambilla et al. 2011; Sinnema et al. 2011) . Both type 1 and type 2 diabetes are more prevalent in individuals with Klinefelter syndrome, with insulin resistance and metabolic syndrome also more common in this population (Gravholt et al. 2011) . Williams syndrome is another condition in which diabetes mellitus is diagnosed more frequently (Pober et al. 2010; Masserini et al. 2013) .
Individuals with Down syndrome (DS) have a lower risk of hypertension and a higher prevalence of type 1 diabetes (Bergholdt et al. 2006) . However, they may have a lower prevalence of type 2 diabetes (Esbensen 2010) . Even if diabetes and hypertension are more prevalent in individuals with ID compared with the general population, studies have reported contradictory results and further research is warranted (Wallace & Schluter 2008; van de Louw et al. 2009; Merrick & Morad 2010; McVilly et al. 2014; Macrae et al. 2015; Emerson et al. 2016b) . Two recent reviews on the prevalence of diabetes in people with IDs reported a mean prevalence of 8.7% (range 3.4-18.5%) (Macrae et al. 2015) and 8.3% (range 0.4-25%) (McVilly et al. 2014) . Undiagnosed cases may be a reason for the diversity of reported results (de Winter et al. 2012a; Wee et al. 2014) .
Surveying medical health for individuals with IDs at a population level is challenging. There are no complete registers, possibly because of the history and stigma associated with diagnoses such as IDs. The overall aim of the present study was to investigate the prevalence of diabetes mellitus, hypertension and obesity in individuals with ID or ASD and compare these with the prevalence of diabetes mellitus, hypertension and obesity in the GP.
Specific aims were to clarify:
1 The prevalence of diabetes mellitus, hypertension and obesity in individuals with IDs or ASD; 2 If the prevalence rates were comparable with those in the GP; and 3 If there were any differences in prevalence between men and women.
Methods

Data sources
The total population of inhabitants in the Stockholm County Council area as at 1 January 2010 was used in this study, together with administrative data for all primary healthcare, specialist outpatient care and inpatient care consultations for people with at least one recorded diagnosis of diabetes mellitus, hypertension or obesity from 1998 to 2015. Data were drawn from VAL, the central administrative database in Stockholm County .
Groups
We stratified the study population (n = 2 023 128) into four groups according to recorded diagnosis (at least one): ID group = intellectual disability, excluding Down syndrome (n = 11 785); ASD group = autism spectrum disorder without any recorded diagnosis of ID (n = 13 921); DS group = Down syndrome (n = 1282) and a GP group (comparison group) = general population without any of these diagnoses (n = 1 996 140). Table 1 presents participant characteristics by sex and age groups.
Selection of diagnoses
The selection of ID diagnoses was based on two recent publications (Lin et al. 2013; Westerinen et al. 2014) , with some changes. Diagnoses for ASD were based on Hirvikoski et al. (Hirvikoski et al. 2016 
Ethics
All data were anonymised and no individuals could be identified. Management and analysis based on the VAL database is part of continuous quality control for healthcare use in Stockholm County Council. Ethical approval was obtained from the Regional Ethic Review Board in Stockholm to study separate diagnoses and concomitant diseases using these data. Numbers given with percentage in each age group within brackets.
Statistical methods
Descriptive statistics were used to present population characteristics. Age-adjusted odds ratios with 95% confidence intervals were calculated using logistic regression analyses to compare the prevalence of diabetes mellitus, hypertension and obesity in individuals with IDs and ASDs with those in the general population. All analyses were stratified by sex. SAS software, version 9.4 (SAS Institute Inc., Cary, NC) was used for statistical analyses and data management.
Results
The characteristics of the study population are presented in Table 1 . The study population included 26 988 individuals with ID, DS or ASD without any recorded diagnosis of ID (1.33% of the total sample) and 1 996 140 individuals from the general population. The studied populations were notably younger than the GP and males were more common in the ID and ASD groups.
Comparison of the distribution of age groups showed that in the DS group, only 19 (1.5%) of the individuals were aged >64 years, and only 17 (0.1%) of the persons were aged >74 years in the ASD group, ( Table 1) . In general, there were large differences in the age distribution between the different groups.
Prevalence of diabetes mellitus, obesity and hypertension and differences between men and women
The prevalence of diabetes mellitus and hypertension in the ID, ASD and DS groups was similar to or lower than the GP group when all age groups were considered together ( Tables 2, 3 ). The prevalence of obesity was higher in the ID, ASD and DS groups compared with the GP group when all ages were considered together and when stratified by age groups. In all four groups, the prevalence of obesity was higher in women compared with men (P < 0.001) ( Table 4) .
When adjusted for age, the prevalence of diabetes mellitus and obesity was higher in the ID, ASD and DS groups compared with the GP group, with the exception of men in the DS group (Table 5) . Hypertension showed a different distribution, being less prevalent in the DS group compared with the GP group, and more prevalent in men in the ID and ASD groups compared with the GP group. Diabetes mellitus was more prevalent in women in the DS group compared with women in the GP group whereas there was no difference between men in these groups. Obesity was more prevalent in both women and men in the DS group compared with the GP group. Hypertension was less prevalent in the DS group compared with the GP group for both men and women.
272 Table 2 Diabetes mellitus in the population of women and men in Stockholm County by 1 Jan 2010, in groups with at least one recorded diagnosis of intellectual disability, Down syndrome or autism spectrum disorder during 1998-2015 in all levels of care, and the general population without any of these diagnosis Diabetes mellitus was more prevalent in both men and women in the ID group compared with the GP group. Obesity was more prevalent in both men and women in the ID group compared with the GP group. Hypertension was more prevalent in men in the ID group compared with the GP group but not so among women.
In the ASD group, diabetes mellitus and obesity were more prevalent in both men and women compared with the GP group. Hypertension was more prevalent in men in the ASD group compared with the GP group but not so among women.
Comorbidity
Analyses of comorbidity using different combinations of any recorded diagnosis of diabetes mellitus, hypertension and obesity from 1998 to 2015 showed some differences. The DS group showed the lowest comorbidity when hypertension was included in the model, 1% had all three diagnoses registered, 2.6% obesity and hypertension and 3.1% diabetes mellitus and hypertension. In the GP group, 4% had all three diagnoses, 5.2% had obesity and hypertension, 14.7% had diabetes mellitus and hypertension and 0.9% had obesity and diabetes mellitus. In the ID group, 5.1% had all three diagnoses, 4.7% had obesity and hypertension, 7.9% had diabetes mellitus and hypertension and 3.6% had obesity and diabetes mellitus. In the ASD group, 3.6% had all three diagnoses, 5.9% had obesity and hypertension, 4.8% had diabetes mellitus and hypertension and 3.2% had obesity and diabetes mellitus.
Discussion
Main findings
Individuals with ID, DS and ASD were up to 3.4 times more likely to have a recorded diagnosis of diabetes mellitus or obesity than the general population. This suggests that these diagnoses are more prevalent because of unhealthy lifestyle choices rather than a specific developmental disability. However, lifestyle may depend on the effect disabilities have on factors such as choices, dependence on others or ability to understand consequences (Emerson & Hatton 2014; Taggart & Cousins 2014) .
The high prevalence of obesity in young ages that we report on (Table 4) has been studied in detail on children in the UK with obesity already at the age of three among children with a developmental delay (Emerson 2009) . At the age of 11, the odds ratio for being obese was 1.68 (1.39-2.03) compared with children without IDs (Emerson et al. 2016a) . This early onset of obesity probably contributes to the increased prevalence of diabetes mellitus and hypertension found in our study. Further studies is warranted to investigate if individuals with IDs or ASDs get access to clinical interventions on how to treat risk factors such as high blood pressure, dyslipidaemia or disturbed glucose metabolism to the same extent as the GP (Collaborators 2017) .
There were some sex differences in the present study. Women in both the ID group and the DS group showed higher odds of diabetes mellitus (2.4-fold, respectively, 1.8-fold) higher than women in the GP group and also higher than men in their own groups. We also report a general higher prevalence of obesity among women in all age groups. In contrast, diabetes mellitus has been reported as more prevalent among men in the GP (Wandell & Carlsson 2014) . The result among men in the DS group with no increased odds for diabetes mellitus needs to be interpreted with caution due to the small number of individuals in the group.
The prevalence of hypertension was higher among men in the ID and ASD groups compared with men in the GP group. A much lower prevalence of hypertension was observed in the DS group, which is 274 Table 5 Age-adjusted odds ratio (OR) comorbidity in women and men with at least one diagnosis of intellectual disability, Down syndrome or autism spectrum disorder (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) in accordance with published data (Richards & Enver 1979) . Thus, the lower prevalence of comorbid diabetes mellitus and hypertension in those with DS was expected. However, our finding that this comorbidity was also less prevalent in those with IDs and ASD needs further investigation. We do not have any explanation for the discrepancy with lower odds for hypertension in women despite the known comorbidity between obesity and hypertension. The small number of individuals in our cohort in older age groups, especially in the DS and ASD groups, may have different explanations. Individuals with DS are known to have a shorter lifespan than the general population, whereas the reason for fewer older individuals in the ASD group may be because diagnoses such as Asperger syndrome have only existed since the 1970s (Rutter 1970) .
Prevalence of diabetes mellitus
Our findings on the prevalence of diabetes mellitus are consistent with a previous population-based study conducted in Ontario, Canada (Balogh et al. 2015) . However, that study did not distinguish between different developmental disability diagnoses, such as DS and ASD. A higher prevalence of diabetes mellitus in people with IDs was also reported in an Australian population-based study (Haider et al. 2013) . That study used self-reported data from proxy respondents for individuals with IDs, and like the Canadian study, did not distinguish between different groups of developmental disabilities (Haider et al. 2013) .
Some countries report no difference in the prevalence of diabetes mellitus among various populations. This may be explained by the process of deinstitutionalization and knowledge among healthcare professionals about IDs, particularly if this contributes to fewer unhealthy living habits and less contact with the healthcare system (Wullink et al. 2009 ). In Sweden, core provision of care changed from a state responsibility in the 1950s to a regional (county) government responsibility in the 1970s and to local (municipality) responsibility from the 1990s (Tossebro et al. 2012) . This has resulted in a change in care provision from physicians specialising in ID to general practitioners that often have little experience with this population (Gillberg & Soderstrom 2003) . Both Sweden and Ontario (Canada) have most of their healthcare systems financed by taxes, meaning that cost is not a barrier to healthcare. Studies that have reported diabetes mellitus as less prevalent in individuals with IDs compared with the GP are generally smaller or were published around the time of to the closing of institutions, which may explain the different results (Janicki et al. 2002; Wallace & Schluter 2008) .
Most earlier reviews on the prevalence of diabetes mellitus in individuals with IDs do not report on differences between men and women (McVilly et al. 2014; Macrae et al. 2015 ). An exception is a Hong Kong study that reported a lower prevalence of diabetes mellitus in men (4.1%) than women (6.6%) in a group with IDs; however, 13.2% of participants had DS (Wong 2011) . A report on the aging population with IDs in the Netherlands showed a higher prevalence of diabetes mellitus in women and a lower prevalence in men compared with the GP (de Winter et al. 2012a) .
In the GP in Sweden, the preponderance of diabetes mellitus in men has increased and is now present in all age groups. Reasons for this include men being more sensitive to abdominal obesity, increased prosperity, travelling by car and a high intake of alcohol (Wandell & Carlsson 2014 ). An explanation for the increased prevalence of diabetes mellitus in women with IDs may be that they have less muscle mass and more abdominal fat compared with males. Unfortunately, we do not know the location of fat among those with obesity in this study.
Prevalence of diabetes mellitus in those with Down syndrome
A higher prevalence of type 1 diabetes in people with DS has been previously reported, although those studies did not discuss sex-based differences (Bergholdt et al. 2006; Rohrer et al. 2010) . In our study, diabetes mellitus was more prevalent in women in the DS group than in the GP group, whereas there was no difference for men. In addition, girls aged 0-18 with DS had the highest percentage (1.97%) of a registered diagnosis of diabetes mellitus, although this group only included five individuals. Type 2 diabetes is reported to be unusual before age 20 years (Wandell & Carlsson 2014 ) and type 1 diabetes has earlier onset in individuals with DS (median age 6 years, range 0-13 years) compared with the GP (8 years, range 0-17), which suggests that those in the younger age group in our study had type 1 diabetes (Bergholdt et al. 2006) . In the GP in Sweden, the incidence of type 1 diabetes in children aged 0-14 years shows no sex-based differences . We found that a diagnosis of diabetes mellitus was present in 4.9% of women with DS aged 19-46 years. These cases may be either type 1 or 2 diabetes, as up to age 30 years, both diabetes type 1 and type 2 are reported in the GP (Wandell & Carlsson 2014) . This, together with diabetes type 1 being more prevalent in individuals with DS (Bergholdt et al. 2006; Taggart et al. 2013) , means that our finding of a higher prevalence in girls and women with DS is of particular interest. To our knowledge, no such findings have been previously reported; however, this finding needs to be replicated and investigated further. Bergholdt et al. (2006) did not report on men and women separately, and Taggart et al. (2013) did not report any differences in their study with adults. In the general population, diabetes (both type 1 and 2) is reported to be more prevalent in men than women in most age groups . A partial explanation for the difference between men and women with DS may be the difference in fat mass distribution between men and women with DS (for type 2 diabetes). Adolescents with DS (aged 10-19 years) showed higher levels of fat and lower lean mass compared with a comparison group without IDs (Gonzalez-Aguero et al. 2011). Compared with children without DS, girls with DS had higher truncal fat mass with lower fat mass in lower limbs, and boys with DS showed higher fat mass levels in the whole body and upper limbs (Gonzalez-Aguero et al. 2011). However, women with DS have been reported to have lower plasma glucose levels compared with women in the general population, which is suggested as a reason for less likelihood of an insulin resistance syndrome (Draheim et al. 2002) .
Prevalence of diabetes mellitus in those with autism spectrum disorder Our finding of a higher prevalence of diabetes mellitus in the ASD group is consistent with a previous report (Taggart et al. 2013) . Another recent study on ASD and type 2 diabetes in adolescents and young adults also supports our results (Chen et al. 2016) . That study controlled for risk factors such as obesity, dyslipidemia, hypertension and atypical antipsychotic medication and reported a prevalence of diabetes mellitus 3.25 times higher than a control group without ASD. They found similar levels between men and women, which also supports our results. The risk factors discussed by Chen et al. (2016) are all associated with a higher prevalence of type 2 diabetes. The comorbidity of obesity, hypertension and diabetes mellitus in the GP is well known and was present in those with ASD in our study, with levels between 3.2-5.9% for different combinations. We did not have information on medication and dyslipidemia.
Prevalence of hypertension
The difference in prevalence of a recorded diagnosis of hypertension between those with IDs and ASD compared with the general population, with hypertension being more prevalent among men than women is supported by previous studies. However, there are also contradictory results, with reports of lower (Kapell et al. 1998; Janicki et al. 2002) , similar (Henderson et al. 2008; van de Louw et al. 2009 ) and higher levels of hypertension in those with IDs or ASD compared with the GP (Sohler et al. 2009; Wee et al. 2014) . Our finding of a higher prevalence of hypertension in men with IDs and ASD may be explained by the higher prevalence of obesity in men compared with women. The studies that reported a lower prevalence of hypertension might have included individuals with DS in the investigated populations, which we, and other researchers, presented separately (Sohler et al. 2009) .
A smaller study previously reported that among adolescents with ID, none had developed hypertension, although other cardio-metabolic risk factors were present (Wallen et al. 2009 ). This contradicts a study with adolescents in Taiwan that reported a hypertension prevalence of 11.7%, which was higher in boys than girls (Lin et al. 2010) . The higher prevalence in men in that study confirms our results and is contrary to reports from the GP that hypertension is more prevalent in women than men .
Odds ratios of hypertension in the DS group were, however, not as high as in all other groups and suggest that DS is only partially protective of hypertension.
Having hypertension together with obesity or diabetes mellitus or both was present among almost 7% in this DS group.
Prevalence of obesity
Some studies have reported that obesity is more prevalent in women with IDs than men (de Winter et al. 2012b; Hsieh et al. 2013 ), although we only found a higher prevalence of obesity in women in the DS group. In contrast, among the GP in Sweden, men have a higher prevalence of obesity (Swedish 2014). Half (49%) of the women with IDs who participated in a health promotion intervention in Stockholm county were reported to have obesity compared with 35% of participating men (Bergstrom et al. 2013) .
Clinical implications
Obesity needs to be prevented in the groups with ID, ASD and DS already at an early age, as consequences from secondary complications such as diabetes mellitus and hypertension are serious and potentially more challenging to control in these groups than in the general population. The life expectancy of individuals with IDs has increased, with those with mild IDs having a similar life span to the GP (Patja et al. 2000) . For individuals with DS, life expectancy increased by 1.8 years per year during the last three decades, resulting in a median age at death of 60 years today (Englund et al. 2013) . This represents an increased need for health promotion. Recently, several papers have reported on premature death in individuals with IDs and ASDs (Hirvikoski et al. 2016; Glover et al. 2017) . The reported cause of death is primarily circulatory diseases, similar to the general population. Evaluated programmes for education in healthy habits targeted to individuals with IDs have been developed, such as the Health Matters programme (Marks et al. 2013) .
Diabetes and hypertension both require early information and education in primary healthcare when preconditions appear, and at a time when it is still possible to reverse the risk by healthier eating habits and increased physical activity (Haymes et al. 2015) . The risk of developing obesity for these populations should also be acknowledged when children are young to ensure parents are informed and aware. The community has a responsibility to reduce health inequalities, and published effective, targeted health promotion information is available (Emerson & Hatton 2014; Taggart & Cousins 2014) . The Swedish Health and Care law (1982) decrees that healthcare should be provided on equal terms. However, the question as to whether individuals with IDs receive healthcare on equal terms merits consideration. Reports from other countries have indicated deficiencies in healthcare use (Heslop et al. 2014; Lunsky et al. 2014) . Recent reports of unnecessary deaths in people with IDs have been attributed to deficiencies in the healthcare received (Heslop et al. 2014) . Countries that have introduced health checks show a beneficial effect on health outcomes, and the higher prevalence of preventable risk factors and diseases reported here is likely to reflect inequalities that are avoidable (Lennox et al. 2011) .
Limitations and strengths
A strength of this study was the clarity of the diagnosis codes used to identify individuals with specific disabilities. In addition, both DS (consisting of the largest specific syndrome group) and ASD (both groups with reported differences in the prevalence of diabetes mellitus, hypertension and obesity) were analysed separately. Another strength was that we reported on differences between men and women.
However, a limitation of this study was that only individuals with a registered diagnosis of ID, DS or ASD were included. In addition, the presence of obesity might be underreported, but it is unknown whether this differs between the GP and the groups with a diagnosis of ID, DS and ASD.
The difference reported between men and women in the DS group must be interpreted with caution due to the small number of subjects in this group.
In Sweden, each individual has a unique personal identification number. We used medical and healthcare records covering the greater Stockholm area, representing one-fifth of Sweden's total population. These records cover all forms of primary healthcare, as well as specialists in ambulatory and in-hospital care. The concomitant conditions were obtained from registered diagnoses and electronic patient records. We consider these two factors make our results reliable.
It was not possible to separate type 1 and type 2 diabetes, as the distinction between these two diagnoses in the electronic patient records was uncertain. However, a diagnosis of type 2 diabetes before age 20 years is unusual, a mixture of type 1 and 2 diabetes is most common up to age 30 years and type 2 diabetes is more common in older individuals (Wandell & Carlsson 2014) .
We have studied associations between prevalence of ID, ASD, DS, diabetes mellitus, hypertension and obesity in Stockholm County 1 January 2010. If the relative survivals after a diagnosis of diabetes mellitus, hypertension or obesity are lower among the studied ID, ASD or DS groups, the true associations may have been underestimated.
Conclusions
Diabetes mellitus and obesity are more prevalent in individuals with IDs, ASD and DS. Hypertension is more prevalent in men with IDs and ASD, whereas women have a higher prevalence of diabetes mellitus. Adapted community-based health promotion programmes needs to be developed to ensure a more equitable health. Based on the high risk of obesity, already during childhood, together with the challenges to treat consequences from obesity, especially diabetes in individuals in these groups, we warrant early prevention and support to healthy living habits.
